Lutetium Lu 177 Dotatate + Octreotide Interaction
Majorinteraction on record
Description
Short-acting octreotide competitively binds to somatostatin receptors and may interfere with LUTATHERA efficacy. Discontinue at least 24 hours prior to each LUTATHERA dose.
Mechanism
Competitive binding to somatostatin receptors
Source: NLP:lutetium lu 177 dotatate